Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoff D.E. Cuvelier, Kirk R. Schultz, Sung Won Choi et al.|Blood|2019Cited by 89
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R. Schultz, Geoff D.E. Cuvelier, Amina Kariminia et al.|Blood|2020Cited by 67
National Institutes of Health (NIH) Consensus Criteria Describe the Clinical Features of Chronic Graft-Versus-Host Disease (cGVHD) in Children and Improve the Accuracy of cGVHD Diagnosis in a Multi-Institution Trial (ABLE / PBMTC 1202)Geoff D.E. Cuvelier, Kirk R. Schultz, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2016Cited by 1
Challenges with Diagnosing Pulmonary Chronic GVHD in Children as Per the 2014 National Institutes of Health Consensus Criteria: Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium (PBMTC) 1202 StudyGeoff D.E. Cuvelier, Kirk R. Schultz, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2017Cited by 0
Recent Thymic Emigrants and Tregs Expressing CD31 and CD45RA Are Decreased at Day 100 and Prognostic for Chronic GvHD in Children: Results From the Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium 1202 StudyGeoff D.E. Cuvelier, Kirk R. Schultz, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2018Cited by 0